Angelo Pan
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- HIV/AIDS drug development and treatment 12
- HIV/AIDS Research and Interventions 7
- Antimicrobial Resistance in Staphylococcus 6
- COVID-19 Clinical Research Studies 6
- Epidemiology 13
- Co-authors
- Evelina Tacconelli (5 shared papers)Giulia De Angelis (3 shared papers)Maria Adriana Cataldo (3 shared papers)Nicola Petrosillo (4 shared papers)Marco Falcone (2 shared papers)B. Cookson (1 shared paper)N Singh (1 shared paper)Uwe Frank (1 shared paper)
- Journals
- Journal of Hospital Infection (4 papers)BMC Infectious Diseases (3 papers)PLoS ONE (3 papers)Infection Control and Hospital Epidemiology (3 papers)Antiviral Therapy (2 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Angelo Pan
66 papers receiving 2.2k citations
Angelo Pan's Hit Papers
Peers
Comparison fields: 5 of 127
- Applied Microbiology and Biotechnology 274
- Molecular Medicine 443
- Infectious Diseases 917
- Virology 179
- Clinical Biochemistry 180
Countries citing papers authored by Angelo Pan
This map shows the geographic impact of Angelo Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Pan more than expected).
Fields of papers citing papers by Angelo Pan
This network shows the impact of papers produced by Angelo Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Pan. The network helps show where Angelo Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Angelo Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients Hit paper breakdown → | 2013 | 646 |
| 2 | 2020 | 124 | |
| 3 | 2020 | 118 | |
| 4 | 2009 | 116 | |
| 5 | 2002 | 101 | |
| 6 | 2014 | 73 | |
| 7 | 2008 | 67 | |
| 8 | 2005 | 60 | |
| 9 | 2014 | 57 | |
| 10 | 2020 | 57 | |
| 11 | 2013 | 48 | |
| 12 | 2000 | 47 | |
| 13 | 2014 | 42 | |
| 14 | 2015 | 42 | |
| 15 | 2020 | 37 | |
| 16 | 2000 | 37 | |
| 17 | 2009 | 33 | |
| 18 | 2008 | 32 | |
| 19 | 2008 | 31 | |
| 20 | 2007 | 30 |
About Angelo Pan
Angelo Pan is a scholar working on Infectious Diseases, Epidemiology, Virology, Surgery and Hepatology, having authored 69 papers that have together received 2.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (12 papers), HIV/AIDS Research and Interventions (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), COVID-19 Clinical Research Studies (6 papers), Antibiotic Use and Resistance (6 papers), Antibiotic Resistance in Bacteria (5 papers) and HIV-related health complications and treatments (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (274 citations), Molecular Medicine (443 citations), Infectious Diseases (917 citations), Virology (179 citations) and Clinical Biochemistry (180 citations). Angelo Pan has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Evelina Tacconelli, Giulia De Angelis, Maria Adriana Cataldo, Nicola Petrosillo, Marco Falcone, B. Cookson, N Singh, Uwe Frank, Mario Venditti and Gunnar Kahlmeter. Their work appears in journals such as Journal of Hospital Infection, BMC Infectious Diseases, PLoS ONE, Infection Control and Hospital Epidemiology and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.